Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced the presentation of updated exploratory subgroup analyses from the SIENDO study in patients with advanced or recurrent TP53 wild-type endometrial cancer at the virtual American Society of Clinical
Summit Financial Group (NASDAQ:SMMF) reported quarterly earnings of $1.16 per share which missed the analyst consensus estimate of $1.19 by 2.52 percent. This is a 22.11 percent increase over earnings of $0.95 per share
Hightower Advisors' Stephanie Link believed one discount retailer's stock offered a buying opportunity so great, she was willing to sell one of her favorite names to jump in.